UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

The antipsychotic potential of l-stepholidine—a naturally occurring dopamine receptor D1 agonist and D2 antagonist

Psychopharmacology, 2008-08, Vol.199 (2), p.275-289

2008

Volltextzugriff (PDF)

Partial agonists in schizophrenia – why some work and others do not: insights from preclinical animal models

The international journal of neuropsychopharmacology, 2011-10, Vol.14 (9), p.1165-1178

2011

Volltextzugriff (PDF)

The dopamine stabilizers (S)-(-)-(3-methanesulfonyl-phenyl)-1-propyl-piperidine [(-)-OSU6162] and 4-(3-methanesulfonylphenyl)-1-propyl-piperidine (ACR16) show high in vivo D2 receptor occupancy, antipsychotic-like efficacy, and low potential for motor side effects in the rat

The Journal of pharmacology and experimental therapeutics, 2006-08, Vol.318 (2), p.810

2006

Volltextzugriff (PDF)

Evaluation of N-desmethylclozapine as a potential antipsychotic--preclinical studies

Neuropsychopharmacology (New York, N.Y.), 2007-07, Vol.32 (7), p.1540-1549

2007

Volltextzugriff (PDF)

Opposite effects of sleep rebound on orexin OX1 and OX2 receptor expression in rat brain

Brain research. Molecular brain research., 2005-05, Vol.136 (1-2), p.148-157

2005

Volltextzugriff (PDF)

Distinct effects of sleep deprivation on binding to norepinephrine and serotonin transporters in rat brain

Progress in neuro-psychopharmacology & biological psychiatry, 2005-02, Vol.29 (2), p.297-303

2005

Volltextzugriff (PDF)

The antipsychotic potential of 1-stepholidine-a naturally occurring dopamine receptor D1 agonist and D2 antagonist

Psychopharmacologia, 2008, Vol.199 (2), p.275-289

2008

Volltextzugriff (PDF)

The antipsychotic potential of l-stepholidine--a naturally occurring dopamine receptor D sub(1) agonist and D sub(2) antagonist

Psychopharmacology, 2008-08, Vol.199 (2), p.275-289

2008

Volltextzugriff (PDF)

The Incidence of Postconcussion Syndrome Remains Stable Following Mild Traumatic Brain Injury in Children

Pediatric neurology, 2015-12, Vol.53 (6), p.491-497

2015

Volltextzugriff (PDF)

Trial of Solanezumab in Preclinical Alzheimer’s Disease

The New England journal of medicine, 2023-09, Vol.389 (12), p.1096-1107

2023

Volltextzugriff (PDF)

Oral versus Intravenous Antibiotics for Bone and Joint Infection

The New England journal of medicine, 2019-01, Vol.380 (5), p.425-436

2019

Volltextzugriff (PDF)

Perception of Recovery After Pediatric Mild Traumatic Brain Injury Is Influenced by the Good Old Days Bias: Tangible Implications for Clinical Practice and Outcomes Research

Archives of clinical neuropsychology, 2014-03, Vol.29 (2), p.186-193

2014

Volltextzugriff (PDF)

Clinical Risk Score for Persistent Postconcussion Symptoms Among Children With Acute Concussion in the ED

JAMA : the journal of the American Medical Association, 2016-03, Vol.315 (10), p.1014

2016

Volltextzugriff (PDF)

Natural Progression of Symptom Change and Recovery From Concussion in a Pediatric Population

JAMA pediatrics, 2019-01, Vol.173 (1), p.e183820

2019

Volltextzugriff (PDF)

Sustained Morphine Delivery Suppresses Bone Formation and Alters Metabolic and Circulating miRNA Profiles in Male C57BL/6J Mice

Journal of bone and mineral research, 2022-11, Vol.37 (11), p.2226-2243

2022

Volltextzugriff (PDF)

Identification of Clinically Viable Quinolinol Inhibitors of Botulinum Neurotoxin A Light Chain

Journal of medicinal chemistry, 2014-02, Vol.57 (3), p.669-676

2014

Volltextzugriff (PDF)

Clinical Benefit of Capsule Endoscopy in Crohn's Disease: Impact on Patient Management and Prevalence of Proximal Small Bowel Involvement

Inflammatory bowel diseases, 2018-06, Vol.24 (7), p.1582-1588

2018

Volltextzugriff (PDF)

Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis

The New England journal of medicine, 2011-10, Vol.365 (16), p.1482-1491

2011

Volltextzugriff (PDF)

Documentation of a New Zealand blue whale population based on multiple lines of evidence

Endangered species research, 2018-01, Vol.36, p.27-40

2018

Volltextzugriff (PDF)

Longitudinal changes in brain metabolites following pediatric concussion

Scientific reports, 2024-02, Vol.14 (1), p.3242-3242, Article 3242

2024

Volltextzugriff (PDF)

Prediction of childhood brain outcomes in infants born preterm using neonatal MRI and concurrent clinical biomarkers (PREBO-6): study protocol for a prospective cohort study

BMJ open, 2020-05, Vol.10 (5), p.e036480-e036480

2020

Volltextzugriff (PDF)

Clinical Correlates of Histopathology in Pediatric Nonalcoholic Steatohepatitis

Gastroenterology (New York, N.Y. 1943), 2008-12, Vol.135 (6), p.1961-1971.e2

2008

Volltextzugriff (PDF)

Do preinjury life events moderate the outcomes of mild traumatic brain injuries in children? An A-CAP Study

Journal of pediatric psychology, 2024-03, Vol.49 (3), p.195-206

2024

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The antipsychotic potential of l-stepholidine—a naturally occurring dopamine receptor D1 agonist and D2 antagonist

Partial agonists in schizophrenia – why some work and others do not: insights from preclinical animal models

The dopamine stabilizers (S)-(-)-(3-methanesulfonyl-phenyl)-1-propyl-piperidine [(-)-OSU6162] and 4-(3-methanesulfonylphenyl)-1-propyl-piperidine (ACR16) show high in vivo D2 receptor occupancy, antipsychotic-like efficacy, and low potential for motor side effects in the rat

Evaluation of N-desmethylclozapine as a potential antipsychotic--preclinical studies

Opposite effects of sleep rebound on orexin OX1 and OX2 receptor expression in rat brain

Distinct effects of sleep deprivation on binding to norepinephrine and serotonin transporters in rat brain

The antipsychotic potential of 1-stepholidine-a naturally occurring dopamine receptor D1 agonist and D2 antagonist

The antipsychotic potential of l-stepholidine--a naturally occurring dopamine receptor D sub(1) agonist and D sub(2) antagonist

The Incidence of Postconcussion Syndrome Remains Stable Following Mild Traumatic Brain Injury in Children

Trial of Solanezumab in Preclinical Alzheimer’s Disease

Oral versus Intravenous Antibiotics for Bone and Joint Infection

Perception of Recovery After Pediatric Mild Traumatic Brain Injury Is Influenced by the Good Old Days Bias: Tangible Implications for Clinical Practice and Outcomes Research

Clinical Risk Score for Persistent Postconcussion Symptoms Among Children With Acute Concussion in the ED

Natural Progression of Symptom Change and Recovery From Concussion in a Pediatric Population

Sustained Morphine Delivery Suppresses Bone Formation and Alters Metabolic and Circulating miRNA Profiles in Male C57BL/6J Mice

Identification of Clinically Viable Quinolinol Inhibitors of Botulinum Neurotoxin A Light Chain

The Global State of the Genetic Counseling Profession

Clinical Benefit of Capsule Endoscopy in Crohn's Disease: Impact on Patient Management and Prevalence of Proximal Small Bowel Involvement

Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis

Documentation of a New Zealand blue whale population based on multiple lines of evidence

Longitudinal changes in brain metabolites following pediatric concussion

Prediction of childhood brain outcomes in infants born preterm using neonatal MRI and concurrent clinical biomarkers (PREBO-6): study protocol for a prospective cohort study

Clinical Correlates of Histopathology in Pediatric Nonalcoholic Steatohepatitis

Do preinjury life events moderate the outcomes of mild traumatic brain injuries in children? An A-CAP Study

Advancing Concussion Assessment in Pediatrics (A-CAP): a prospective, concurrent cohort, longitudinal study of mild traumatic brain injury in children: protocol study

Suchergebnisse filtern